3Wojdas A, Rapiejko P, Zielnik-Jurkiewicz B, et al. Nasal provocative test in patients allergic to pollen [J]. Ann Agric Environ Med, 2005, 12(2): 173-176.
4Choo-Kang LR. Specific IgE testing: Objective laboratory evidence supports allergy diagnosis and treatment [J]. MLO Med Lab Obs, 2006, 38(3): 10-12, 14, 17, quiz 20-21.
5Oppenheimer J, Nelson HS. Skin testing: a survey of allergists [J]. Ann Allergy Asthma Immunol, 2006, 96(1): 19-23.
6Barck C, Lundahl J, Hallden G, et al. Total eosinophil cationic protein levels in induced sputum as a marker of changes in eosinophilic inflammation in a patient with allergic asthma [J]. Ann Allergy Asthma Immunol, 2005, 95 (1) : 86-92.
7Sohn MH, Lee SY, Lee KE, et al. Comparison of VIDAS stallertest and pharmacia CAP assays for detection of specific IgE antibodies in allergic children [J]. Ann Clin Lab Sci, 2005, 35 (3): 318-322.
8Bradford TJ, Wang X, Chinnaiyan AM. Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer [J]. Urol Oncol, 2006, 24(3): 237-242.
9Harwanegg C, Hiller R. Protein microarrays for the diagnosis of allergic diseases: state-of-the-art and future development [J]. Clin Chem Lab Med, 2005, 43(12): 1321-1326.
10Wohrl S, Vigl K, Zehetmayer S, et al. The performance of a component-based allergen-microarray in clinical practice [J]. Allergy, 2006, 61(5): 633-639.
7Katelaris CH, Peake JE. Allergy and the shin., eczema and chronic urticaria[J]. Med J Aust, 2006,185 (9) .. 517-522.
8Plebani M,Borghesan F.Clinical efficiency of in vitro and in vivo tests for allergic diseases[J].Ann Allergy Asthma Immunol,1995,74(6):23-28.
9William PB,Dolen WK.Comparison of skin testing and three in vitro assays for specific IgE in the clinical evaluation of immediate hypersensitivity[J].Ann Allergy,1992,68(15):35-42.
10Kelso JM,Sodhi N.Diagnositic performance characteristic of the standard Phadebas RAST,and Pharmacia CAP system versus skin testing[J].Ann Allergy,1991,67(21):511-514.